2,275
Participants
Start Date
December 3, 2018
Primary Completion Date
May 31, 2019
Study Completion Date
May 31, 2019
No treatment given
No specific intervention is studied. All anti-diabetic and CV medication will be prescribed at the physician's discretion under routine clinical practice conditions.
Novo Nordisk Investigational Site, Savigliano (CN)
Novo Nordisk Investigational Site, Prague
Novo Nordisk Investigational Site, Rozzano (MI)
Novo Nordisk Investigational Site, Milan
Novo Nordisk Investigational Site, Brandýs nad Labem
Novo Nordisk Investigational Site, Montélimar
Novo Nordisk Investigational Site, Chartres
Novo Nordisk Investigational Site, Benátky nad Jizerou
Novo Nordisk Investigational Site, Pilsen
Novo Nordisk Investigational Site, Negrar (VR)
Novo Nordisk Investigational Site, Chomutov
Novo Nordisk Investigational Site, Ferrara
Novo Nordisk Investigational Site, Ravenna
Novo Nordisk Investigational Site, Bagno a Ripoli
Novo Nordisk Investigational Site, Florence
Novo Nordisk Investigational Site, Hradec Králové
Novo Nordisk Investigational Site, Fano
Novo Nordisk Investigational Site, Courpière
Novo Nordisk Investigational Site, Strasbourg
Novo Nordisk Investigational Site, Boskovice
Novo Nordisk Investigational Site, Břeclav
Novo Nordisk Investigational Site, Lyon
Novo Nordisk Investigational Site, Tarare
Novo Nordisk Investigational Site, Vénissieux
Novo Nordisk Investigational Site, Sathonay-Camp
Novo Nordisk Investigational Site, Ostrava
Novo Nordisk Investigational Site, Le Creusot
Novo Nordisk Investigational Site, Ostrava
Novo Nordisk Investigational Site, Brindisi
Novo Nordisk Investigational Site, Orlová
Novo Nordisk Investigational Site, Saint-Saëns
Novo Nordisk Investigational Site, Kroměříž
Novo Nordisk Investigational Site, Olomouc
Novo Nordisk Investigational Site, Napoli
Novo Nordisk Investigational Site, Ariano Irpino
Novo Nordisk Investigational Site, Catanzaro
Novo Nordisk Investigational Site, Partinico (PA)
Novo Nordisk Investigational Site, Messina
Novo Nordisk Investigational Site, Albano Laziale
Novo Nordisk Investigational Site, Orvieto
Novo Nordisk Investigational Site, Roma
Lead Sponsor
Novo Nordisk A/S
INDUSTRY